Preventive effects of oxytocin and oxytocin receptor in breast cancer pathogenesis

Per Med. 2019 Jan;16(1):25-34. doi: 10.2217/pme-2018-0009. Epub 2018 Nov 19.

Abstract

Aim: Modifications of oxytocin (OT) concentration and OT receptor (OXTR) expression level have different effects on breast cancer-derived cells. This study was conducted to evaluate OT variation in breast cancer patients and to evaluate OXTR expression changes in breast cancer tissues.

Methods: The plasma concentrations of OT in both breast cancer patients and healthy individuals' samples were assessed. OXTR variations were then assessed in both cancerous and noncancerous breast tissues.

Results: OT had an increase in breast cancer patients and expression of OXTR in contralateral breast was more than cancerous tissues.

Conclusion: Despite the high levels of OT concentration in breast cancer patients, it seems that a lower expression of OXTR in cancerous tissues can be effective in the breast cancer progression.

Keywords: breast cancer; gene expression; oxytocin; oxytocin receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Breast Neoplasms / genetics*
  • Female
  • Gene Expression Regulation, Neoplastic / genetics
  • Humans
  • Middle Aged
  • Oxytocin / blood
  • Oxytocin / pharmacology
  • Oxytocin / therapeutic use*
  • Receptors, Oxytocin / genetics*
  • Receptors, Oxytocin / metabolism
  • Receptors, Oxytocin / physiology
  • Transcriptome / genetics

Substances

  • OXTR protein, human
  • Receptors, Oxytocin
  • Oxytocin